Perrigo
Headquartered in Ireland, Perrigo Company plc is a global healthcare supplier that develops, manufactures and distributes over-the-counter (OTC) and generic prescription (Rx) pharmaceuticals, infant formulas, nutritional products, animal health, dietary supplements, active pharmaceutical ingredients (API), and medical diagnostic products and receives royalties from Multiple Sclerosis drug Tysabri.
In 2013 it acquired Irish pharma company Elan.
Financial Data
-
31st Dec 19 Source: CRO
- €4.4 billion turnover
-
€154.4 million
profit - 10,400 employees
-
31st Dec 18 Source: CRO
- €4.2 billion turnover
-
€255.3 million
profit - 10,400 employees
- 5 more years available »
Ranking
By Turnover
(€4.4 billion)- 29th in Top Companies
- 5th in Health
- 5th in Pharma
By Employees
(10,400)- 22nd in Top Companies
- 4th in Health
- 4th in Pharma
-
- 10,400
- €4.4 billion
Employees
- Murray S. Kessler CEO/Managing Director
Latest News
- Jul 06 All parties to High Court hearings told to wear facemasks
- Jul 06 Deloitte was top Irish dealmaker in first half of this year
- Jul 06 Dublin council puts Unicorn restaurant demolition plan on hold
- Jul 06 Dispute over €2.95m sale of Georgian property struck out
- Jul 06 Global markets surge after positive economic news in Far East